跳至主要内容
临床试验/CTRI/2024/10/075318
CTRI/2024/10/075318尚未招募3 期

RANDOMIZED CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF AGNIKARMA WITH SUVARNSHALAKA IN THE MANAGEMENT OF GRIDHRASI WITH SPECIAL REFERENCE TO SCIATICA.

DrShubham Patil1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年10月18日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
pain relief,increase leg range of movement

研究概览

简要总结

The prevalence of Gridhrasi is 1.2%, Untreated Gridhrasi can cause problems such as: erectile dysfunction (ED), menstrual problems, constipation, incontinence, urinary problems, leg swelling or edema, reproductive issues, and other problems. Gridhrasi is the commonest disease we observed as per the previous research there are various drugs that have been explored scientifically on Gridhrasi while reviewing the literature it was observed Agni karm with suvarnashalaka was not much studied till date hence hoping this studing may contribute further to public health. we have decided to use Agni karma with suvarnashalaka in the management of Gridhrasia

The effect of the Kati Basti on different parameters gridhrasi. After a course of the Kati Basti, the analysis of the patients revealed that there is a statistically significant improvement seen in the parameters like sthambha, Ruk, toda, magnitude of pain, neurological deficit, functional ability, and functional disability.

Agnikarma are simple, cheap, safe, and effective in the management of Gridhrasi but Agnikarma is more effective than Siravedha in relieving the main symptoms of the disease.

Pain is chief cause of visiting a doctor in most patient. it is known asruja which is one of the symptoms of gradhrasi. It disturb physical and mental status of patient.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Patient having age group of 30-70 yrs.
  • Irrespective of any gender, any socioeconomic site occupation.
  • Patient with sign and symptoms sciatica.

排除标准

  • Patient associated with known H/O any spinal surgery.
  • Malignancy, Lumbar Spine injury.
  • Osteoarthritis, Osteoporosis, Scoliosis.

结局指标

主要结局

pain relief,increase leg range of movement

时间窗: 1st,7th,14th dayu

次要结局

  • easy to walk(14th day)

研究者

发起方
DrShubham Patil
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DrShubham Vilas Patil

Chhatrapati shahu maharaj shikshan sanstha Ayurved Mahavilayadya

研究点 (1)

Loading locations...

相似试验